Navin Khosla NowPatientGreen tick

Navin Khosla

UK Responsible Person (UKRP), Pharmacist Independent Prescriber, Clinical Safety Officer (CSO), Pharmacist

On this page

  1. About
  2. Education
  3. Licensure
  4. Affiliations
  5. Professional accomplishments
  6. About our medical review process

Expertise

Community Pharmacy
Safeguarding
Drug Interactions
Medical Writing
CQC
Clinical Safety
NHS
Travel Health Advisor

Follow me

GPhC number

2043964

Qualifications

B.Pharm

About

Navin Khosla is NowPatient’s clinical safety officer (CSO), medical content reviewer, and registered pharmacist. He qualified with a degree in Pharmacy B.Pharm (Faculty of Medicine) at the University of London, School of Pharmacy, and obtained a professional qualification as a Pharmacist in July 1995. Since qualifying, He has built a wealth of experience by working across the health tech and community pharmacy retail sectors. He is also a Pharmacist Independent Prescriber and UK Responsible Person for NowPatient Class 1 Medical Device.

Education

  • The UCL School of Pharmacy

Licensure

Affiliations

  • General Pharmaceutical Council (GPhC)
  • Royal Pharmaceutical Society (RPS)

Professional accomplishments

  • Registered clinical safety officer
  • CQC care manager
  • Flu vaccinations accreditation
  • Safeguarding
  • New medicines service
  • Travel Health Advisor
  • Pharmacist Independent Prescriber
  • UK Responsible Person for NowPatient Class 1 Medical Device

About our medical review process

At NowPatient, we are committed to providing users with clear, evidence-based health and wellness information. We aim to be your most trusted source of information and to that end, our content is medically reviewed. Medical review is provided using an approved panel who have years of clinical practice and/or academic exposure.

Latest Blog Articles

Blog
An image depicting a box of Lynkuet and the red Lynkuet capsules

Veoza vs Lynkuet

Medically reviewed by Navin Khosla
Read More
Blog
Vision Loss Warning for Ozempic and Wegovy

Vision Loss Warning for Ozempic Wegovy: Alert on Semaglutide Linked to Rare Eye Condition

Medically reviewed by Navin Khosla
Read More
Blog
Comparing Pen Prices

Best Prices for Weight Loss Medications Online

Medically reviewed by Navin Khosla
Read More
Blog
Rybelsus Tablets

Discover the New Formulation Rybelsus Tablets

Medically reviewed by Navin Khosla
Read More
Blog
Image of Mounjaro Kwikpen and Wegovy Flexpen

What You Need to Do When Travelling with Your Weight Loss Jabs

Medically reviewed by Navin Khosla
Read More
Blog
Image of patient seeing a NowPatient clinician over a live video feed

Buy Weight-Loss Injections Online: Quiz-Based or Video-Consult – What’s Safer?

Medically reviewed by Navin Khosla
Read More
Blog
Frankenstein Covid

What You Need to Know About the Stratus COVID Variant XFG

Medically reviewed by Navin Khosla
Read More
Blog
MariTide

Update on Once-Monthly Weight Loss Drug MariTide following Phase II Clinical Trial

Medically reviewed by Navin Khosla
Read More